Roles of miRNAs in regulating the differentiation and maturation of myeloid-derived suppressor cells

Medical Hypotheses

Volumn 83, Issue 2, 2014, Pages 151-153

  Tian, Jie ^a   Rui, Ke ^a   Wang, Shengjun ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; NUCLEAR FACTOR; NUCLEAR FACTOR 1A; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; NFIA PROTEIN, HUMAN; NUCLEAR FACTOR I; RUNX1 PROTEIN, HUMAN;

ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; GENE TARGETING; MYELOID DERIVED SUPPRESSOR CELL; MYELOID PROGENITOR CELL; NONHUMAN; SUPPRESSOR CELL; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; NEOPLASM;

CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE TOLERANCE; MICRORNAS; MODELS, IMMUNOLOGICAL; MYELOID CELLS; NEOPLASMS; NFI TRANSCRIPTION FACTORS;

EID: 84902799423     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.05.006     Document Type: Article

References (39)

1. Curiel T.J. Regulatory T cells and treatment of cancer. Curr Opin Immunol 2008, 20(2):241-246.
2. Berzofsky J.A., Terabe M. NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J Immunol 2008, 180(6):3627-3635.
3. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukocyte Biol 2009, 86(5):1065-1073.
4. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007, 117(5):1155-1166.
5. Talmadge J.E. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin Cancer Res 2007, 13(18):5243-5248.
6. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9(3):162-174.
7. Peranzoni E., Zilio S., Marigo I., et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010, 22(2):238-244.
8. Movahedi K., Guilliams M., Van den Bossche J., et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008, 111(8):4233-4244.
9. + T cell tolerance in cancer. Nat Med 2007, 13(7):828-835.
10. Liu C., Yu S., Kappes J., et al. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 2007, 109(10):4336-4342.
11. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006, 66(2):1123-1131.
12. Serafini P., Mgebroff S., Noonan K., Borrello I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 2008, 68(13):5439-5449.
13. Pan P.-Y., Ma G., Weber K.J., et al. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 2010, 70(1):99-108.
14. Youn J.-I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008, 181(8):5791-5802.
15. Bronte V., Zanovello P. Regulation of immune responses by l-arginine metabolism. Nat Rev Immunol 2005, 5(8):641-654.
16. Saleem S.J., Martin R.K., Zellner H.B., Nguyen G.-K., Conrad D.H. Mast cells and mast cell derived-histamine promote the recruitment and immunoregulatory activity of myeloid derived suppressor cells. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). http://dx.doi.org/10.3389/conf.fimmu.2013.02.00985.
17. Bernstein E., Kim S.Y., Carmell M.A., et al. Dicer is essential for mouse development. Nat Genet 2003, 35(3):215-217.
18. Ambros V. The functions of animal microRNAs. Nature 2004, 431(7006):350-355.
19. Neilson J.R., Zheng G.X., Burge C.B., Sharp P.A. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007, 21(5):578-589.
20. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003, 113(6):673-676.
21. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., Taganov K.D. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008, 9(8):839-845.
22. Zhang B., Farwell M.A. MicroRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 2008, 12(1):3-21.
23. Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302(1):1-12.
24. Krutzfeldt J., Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab 2006, 4(1):9-12.
25. Pauley K.M., Cha S., Chan E.K. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009, 32(3-4):189-194.
26. Zhang M., Liu Q., Mi S., et al. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J Immunol 2011, 186(8):4716-4724.
27. Liu Y., Lai L., Chen Q., et al. MicroRNA-494 Is Required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J Immunol 2012, 188(11):5500-5510.
28. Johnnidis J.B., Harris M.H., Wheeler R.T., et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451(7182):1125-1129.
29. O'Connell R.M., Zhao J.L., Rao D.S. MicroRNA function in myeloid biology. Blood 2011, 118(11):2960-2969.
30. + myeloid-derived suppressor cells from bone marrow cells. Int J Cancer 2011, 129(11):2662-2673.
31. Chen C.-Z., Lodish H.F. MicroRNAs as regulators of mammalian hematopoiesis. Semin Immunol 2005, 17(2):155-165.
32. Zhao J.L., Rao D.S., Boldin M.P., Taganov K.D., O'Connell R.M., Baltimore D. NF-κB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci 2011, 108(22):9184-9189.
33. Pelosi E., Labbaye C., Testa U. MicroRNAs in normal and malignant myelopoiesis. Leuk Res 2009, 33(12):1584-1593.
34. Han Y.C., Park C.Y., Bhagat G., et al. MicroRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 2010, 207(3):475-489.
35. Velu C.S., Baktula A.M., Grimes H.L. Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood 2009, 113(19):4720-4728.
36. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303(5654):83-86.
37. Rosa A., Ballarino M., Sorrentino A., et al. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci 2007, 104(50):19849-19854.
38. Fazi F., Rosa A., Fatica A., et al. A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 2005, 123(5):819-831.
39. Fontana L., Pelosi E., Greco P., et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007, 9(7):775-787.